Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/30/2002 | CN1333685A Utilisation of I compound for the prophylaxis and therapy of cerebral ischaemia |
01/30/2002 | CN1332962A Process for prepairng weedicide imidazolinone compound |
01/29/2002 | US6342765 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
01/29/2002 | US6342608 Reacting organometallic reagent with activated carboxylic acid to form ketone, treating with mixture of carbon disulfide and dihalomethane to form dithietane, reacting with hydrazine derivative to form thiol-substituted pyrazole, alkylating |
01/29/2002 | US6342604 Treating schizophrenia, depression, neuroses and psychoses which respond to dopamine d3 ligands |
01/29/2002 | US6342512 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
01/29/2002 | US6342505 Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-β1 |
01/29/2002 | US6342504 Peptides as antithrombins and anticoagulants |
01/29/2002 | US6342503 Antidepressants, eating disorders |
01/29/2002 | US6342500 Antidiabetic agents |
01/29/2002 | US6342498 Arylpiperazines as serotonin reuptake inhibitors and 5-HT1Dα antagonists |
01/29/2002 | CA2165996C Stereoselective preparation of 2-substituted succinic derivatives |
01/28/2002 | CA2704693A1 Indole derivatives and their use as medicaments |
01/28/2002 | CA2704691A1 Indole derivatives and their use as medicaments |
01/24/2002 | WO2002006512A2 Method for detecting uracil biosynthesis inhibitors and their use as herbicides |
01/24/2002 | WO2002006280A2 INHIBITORS OF FACTOR Xa |
01/24/2002 | WO2002006276A1 Beta3 adrenergic agonists |
01/24/2002 | WO2002006274A1 N-(4-sulfonylaryl)cyclylamine-2-hydroxyethylamines as beta-3 adrenergic receptor agonists |
01/24/2002 | WO2002006273A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
01/24/2002 | WO2002006272A1 Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof |
01/24/2002 | WO2002006271A1 Pyrimidine derivatives |
01/24/2002 | WO2002006270A1 Novel 6-heteroarylphenanthridines |
01/24/2002 | WO2002006255A2 Hydroxy-(piperidin-4-yl-methylamino)-alkyl beta-3 adrenergic receptor antagonists |
01/24/2002 | WO2002006252A1 Asymmetric dihydrotriazines as pesticides |
01/24/2002 | WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors |
01/24/2002 | WO2002006246A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
01/24/2002 | WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
01/24/2002 | WO2002006240A1 Substituted 4,9-dihydrocyclopenta[imn] phenanthridine-5-ones, derivatives thereof and their uses |
01/24/2002 | WO2002006236A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
01/24/2002 | WO2002006234A1 Sulfone derivatives, process for their production and use thereof |
01/24/2002 | WO2002006232A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
01/24/2002 | WO2002006231A1 Serotonin reuptake inhibitors |
01/24/2002 | WO2002006229A2 Heterocyclic beta-3 adrenergic receptor agonists |
01/24/2002 | WO2002006224A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
01/24/2002 | WO2002006223A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
01/24/2002 | WO2002006222A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
01/24/2002 | WO2002006221A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
01/24/2002 | WO2002005819A1 Compounds and methods |
01/24/2002 | WO2002005616A1 Novel 6-phenylphenanthridines |
01/24/2002 | WO2001060814A3 Pyrrole substituted 2-indolinone protein kinase inhibitors |
01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
01/24/2002 | WO2001053268B1 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
01/24/2002 | WO2001023357A3 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
01/24/2002 | US20020010343 Compounds having IgE affecting properties |
01/24/2002 | US20020010338 Phenyl-keto-imidazolidine thioamide derivatives |
01/24/2002 | US20020010235 Flame retardant compositions |
01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
01/24/2002 | US20020010204 Use as pesticides. |
01/24/2002 | US20020010188 Salt form and polymorphs |
01/24/2002 | US20020010186 Dihydropyrimidines and uses thereof |
01/24/2002 | US20020010185 Anticarcinogenic agents |
01/24/2002 | US20020010184 Inhibitors of prenyl-protein transferase |
01/24/2002 | US20020010182 Treatment of respiratory diseases such as asthma, bronchitis, rhinitis, cough, expectoration, ophthalmic diseases such as conjunctivitis, dermatitis |
01/24/2002 | US20020010181 Angiogenesis inhibitors as antitumor agents |
01/24/2002 | US20020010177 For treating eosinophil-dependent inflammatory diseases, asthma |
01/24/2002 | US20020010176 Integrin receptor antagonists |
01/24/2002 | US20020010174 1,4-diazepine-2-one derivatives as neurokinin antagonist |
01/24/2002 | US20020010173 Reacting an amide derivative with a piperidine containing guanidine group to produce the product |
01/24/2002 | US20020010155 Novel process |
01/24/2002 | US20020010120 Composition and method for bleaching a substrate |
01/24/2002 | US20020007585 Transition-metal-catalyzed process for the preparation of sterically hindered N-substituted aryloxyamines |
01/24/2002 | US20020007522 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
01/24/2002 | US20020007521 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
01/24/2002 | DE19963234A1 New N,N-disubstituted piperazine and diazacycloheptane derivatives useful in treatment of hyperlipidemia, atherosclerosis, diabetes mellitus, adiposity and pancreatitis |
01/24/2002 | CA2418288A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
01/24/2002 | CA2416667A1 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
01/24/2002 | CA2416384A1 Sulfone derivatives, their production and use |
01/24/2002 | CA2416245A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
01/24/2002 | CA2416039A1 Method for detecting uracil biosynthesis inhibitors and their use as herbicides |
01/24/2002 | CA2416036A1 Substituted amidoalkyl-uracils as parp inhibitors |
01/24/2002 | CA2415935A1 Novel 6-heteroarylphenanthridines |
01/24/2002 | CA2415665A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
01/24/2002 | CA2415331A1 Beta3 adrenergic agonists |
01/24/2002 | CA2415126A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
01/24/2002 | CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
01/23/2002 | EP1173468A1 Integrin receptor antagonists |
01/23/2002 | EP1173432A1 Piperidine-indole compounds having 5-ht6 affinity |
01/23/2002 | EP1173424A1 Pyrimidine compounds |
01/23/2002 | EP1173421A2 Indole derivatives as anti-inflammation agents |
01/23/2002 | EP1173212A1 Contraceptive compositions contaning indolone derivatives and progestational agents |
01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
01/23/2002 | EP0888291B1 New process for preparing pesticidal intermediates |
01/23/2002 | CN1332731A Substituted benzimidazoles and their prep. and use |
01/23/2002 | CN1332730A Process for preparing insecticide |
01/23/2002 | CN1332727A 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
01/23/2002 | CN1332166A Process for prep. of N-methyl-3-(1-methyl-4-piperidyl)-1H-indole-5-ethyl-sulfonamide |
01/22/2002 | US6340761 Amination and dehydrohalogenation with piperidine compounds |
01/22/2002 | US6340759 Fused pyridine derivatives |
01/22/2002 | US6340758 Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
01/22/2002 | US6340704 Cell differentiation inducing amide derivatives, their production and use |
01/22/2002 | US6340685 Antiinflammatory agents |
01/22/2002 | US6340684 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
01/22/2002 | US6340683 Selective NPY (Y5) antagonists (triazines) |
01/22/2002 | US6340681 Useful as analgesics in mammals |
01/22/2002 | US6340678 4,4-difluoro-2,3,4,5-tetrahydro-1H-1-benzoazepine derivatives and drug compositions containing them |
01/22/2002 | CA2237971C Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
01/21/2002 | CA2353369A1 Novel heteroaryl derivatives and their use as medicaments |
01/17/2002 | WO2002004447A1 Variolin derivatives as anti-cancer agents |
01/17/2002 | WO2002004440A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |